Loss-of-function mutations in the chromatin remodeling protein, alpha-thalassemia/mental retardation syndrome X-linked (ATRX), which occur in the majority of LGAs, are associated with induction of the ALT pathway, and ATRX re-expression has been shown to repress the ALT pathway4,11–13. Here, ATRX is linked to thalassemia.